Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9929
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhanuja, Harmeet Singh-
dc.date.accessioned2021-08-10T10:28:24Z-
dc.date.available2021-08-10T10:28:24Z-
dc.date.issued2021-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9929-
dc.description.abstractRP-HPLC SIAM has been developed and validated for the assessment of salbutamol sulfate in inhalational solution on an adopted compendial method. The method was tested for its feasibility and specificity to separate the principal component, related substances and impurities from the prepared in-house formulation undergoing stability studies. The studies elaborate feasibility testing of adopted method optimization of forced degradation studies to achieve 10-30% degradation of API as such and in formulation. The API and formulation were exposed to stressful condition for 7 days and the were analyzed using a waters column Symmetry C8 (150mm x 3.9mm) 5μm make waters or equivalent at 25°C on a flow rate of 1.0mL/min for over 50 minutes Detection wavelength used was 220nm ACN and Phosphate buffer of pH 3.65 as composite mobile phase. The optimized method was then validated as per the ICH guidelines(Q2A).en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Analysisen_US
dc.subject19MPHen_US
dc.subject19MPH305en_US
dc.subjectPDR00685en_US
dc.titleValidation and Assessment of Stability Indicating RP-HPLC Method For Salbutamol Sulfate in Inhalational Solution and Forced Degradation Studyen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00685_19MPH305.pdfPDR006852.91 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.